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Abstract
Background: The haematological profile of the pregnant woman has an impact on the outcome of the
pregnancy. Published guidelines indicate acceptable levels for haematological indices in pregnancy but they
are population specific. Indicators of haemoglobin concentration are the most commonly utilized of the
indices. These published international norms are used across populations, however, there is no evidence
confirming their applicability to a population such as the Jamaican pregnant woman. This study was
therefore undertaken with the intent of documenting the haematological profile of pregnant primigravid
Jamaican women and comparing these to the established norms to determine whether the norms apply
or whether there was a need to establish local norms.
Methods: This was a longitudinal study done on a cohort of 157 healthy primigravid women ages 15 to
25 and without anaemia, and who were recruited from the antenatal clinic of the University Hospital of
the West Indies, Kingston, Jamaica. The haemoglobin concentration, packed cell volume, mean cell volume,
mean cell haemoglobin, mean cell haemoglobin concentration, white blood cell count, red blood cell count
and platelet count were measured on samples of blood obtained from each consenting participant during
each of the three trimesters. The results were analysed using SPSS for windows (Version 11) and the data
expressed as means ± S.D. Means were compared using the student's paired t-test. Comparison was then
made with the international norms as recommended by the United States Center for Disease Control
(1989). Ethical approval for this study was obtained from the University Hospital of the West Indies/
University of the West Indies Ethics Committee.
Results: The results showed changes by trimester in all measured variables. For most of the indices the
changes achieved levels of significance across trimesters. These changes were however in keeping with the
expected physiological response in pregnancy and the values were similar to the published international
norms.
Conclusion: The findings suggest that the international norms for haematological indices in pregnancy are
applicable across populations and to the pregnant Jamaican primigravid woman. This finding may be
reassuring to others with a similar population and stage of development as Jamaica.
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Background
The haematological profile of an individual to a large extent
reflects their general health [1] and many studies have iden-
tified the haematological profile of the pregnant woman as
one of the factors affecting pregnancy and its outcome [2-
7]. The most commonly referred to of the haematological
indices are the indicators of haemoglobin concentration,
and low haemoglobin (anaemia) is the most widely identi-
fied haematological abnormality [8] and is associated with
adverse pregnancy outcome [3-5]. Anaemia in women is
variously defined with the two most common being either
as a haemoglobin concentration less than 11.0 g/dl or <5th
percentile of the distribution of haemoglobin concentra-
tion or Haematocrit in a healthy reference population and
is based on age, sex, and (among pregnant women) stage of
pregnancy. According to the World Health Organisation,
"anaemia is a common and serious problem in pregnancy"
and needs to be addressed [9].
Since the assessment of haematological status is possible
through a series of tests measuring different variables it is
valuable to have norms for the haematological indices.
Although profiles are generally available in the published
literature as established norms [8], there is no evidence
that any studies were done to assess the applicability of
these norms across populations and especially to the
Jamaican primigravid patient. Such a study is of impor-
tance since antenatal care and pregnancy outcome is in
part, predicated on the monitoring of and response to
these haematological indices [2-9]. It is therefore the
intent of this study to investigate the haematological pro-
file of pregnant primigravid Jamaican women and com-
pare these to the established norms to determine whether
the norms apply or if there is a need to establish local
norms. We believe that this information could also be of
benefit to other countries with a similar population and
stage of development as Jamaica.
Methods
The definition of anaemia as used in this study was a hae-
moglobin of <11.5 g/dl. The results are also compared
with the finding if the definition of <5th percentile, quoted
above, was used. One hundred and fifty seven (157) prim-
igravid women between the ages of 15 and 25 were
recruited on their first visit to the antenatal clinic at the
University Hospital of the West Indies. The first visit is
usually made at 9–12 weeks gestation. Both oral and writ-
ten consent was obtained from each participant. The
Inclusion criteria included age 15 to 25, primigravida sta-
tus, haemoglobin 11.0 g/dl or greater, and no history of
chronic illness. Exclusion criteria included age younger
than 15 and older than 25, not primigravid, history of
anaemia or chronic illness. The age limit of 15 to 25 was
chosen as it was felt they are more likely to represent a
healthy segment of the pregnant population. After enrol-
ment in the study, 5 ml of venous blood was drawn and
anticoagulated with K+ EDTA at a concentration of 1.5
mg/ml. Blood samples were again obtained at 26 – 28 and
36 – 38 weeks gestational age. The blood samples were
analyzed for haemoglobin (Hb), packed cell volume
(PCV), mean corpuscular haemoglobin (MCH), mean
corpuscular haemoglobin concentration (MCHC), mean
corpuscular volume (MCV), red blood cells (RBC), plate-
lets (Plt) and white blood cells (WBC) by means of an
automated Coulter Counter Ac.T diff™ Analyzer. All meas-
urements were made within 2 hours of Venepuncture.
Data analysis was done using SPSS for windows (Version
11) and the data expressed as means ± S.D. Means were
compared using the student's paired t-test. Comparison
was made with the international reference levels as well as
with the 5th  percentile for the study group. Ethical
approval for this study was obtained from the University
Hospital of the West Indies/University of the West Indies
Faculty of Medical Sciences Ethics Committee.
Results
General characteristics of the cohort
Table 1 shows the demographic profile of the participants.
The average age was 20.31 ± 2.33 yrs, while average height
was 162.70 ± 7.43 cm. The average weight of the partici-
pants increased progressively over the three trimesters of
pregnancy.
Table 1: Demographic characteristics of participants
Age group (yrs) Age (yrs) Height (cm) Trimester 1 
weight (kg)
Trimester 2 
weight (kg)
Trimester 3 
weight (kg)
15 – 19 Mean 17.98 163.03 62.60 69.780 75.29
N 6 15 25 45 04 3
Std. Deviation 1.18 5.87 15.12 15.5126 15.74
20 – 25 Mean 21.79 162.47 66.09 73.042 76.29
N 9 67 88 87 36 6
Std. Deviation 1.535 8.34 16.41 16.0908 15.92
Total Mean 20.31 162.69 64.76 71.716 75.90
N 157 130 142 123 109
Std. Deviation 2.331 7.43 15.97 15.8758 15.78BMC Pregnancy and Childbirth 2008, 8:8 http://www.biomedcentral.com/1471-2393/8/8
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Haemoglobin pattern over the three trimesters
The results indicate that the haemoglobin concentration is
highest in the first trimester, reaches its lowest point in the
second trimester and begins to rise again in the third tri-
mester (Table 2). The mean haemoglobin concentration
was 12.73 ± 1.14 g/dl in the first trimester, 11.41 ± 1.16 g/
dl in the second trimester and 11.67 ± 1.18 g/dl in the
third trimester. These results are similar to those pub-
lished by the Centers for Disease Control (CDC) using
data from four European surveys of healthy women taking
iron supplements [8] and the National Health and Nutri-
tion Examination Survey (NHANES) [10].
Other haematological indices across trimesters
A similar trend in changes in concentration to that for the
haemoglobin mentioned above, is also seen in the packed
cell volume and the red blood cell count (Table 2). In con-
trast, the mean corpuscular volume and the mean cell hae-
moglobin had the lowest value in the first trimester, rose
to its highest value in the second trimester and then
started to decline in the third trimester. The mean corpus-
cular haemoglobin concentration however, remained
fairly constant throughout pregnancy. The white blood
cell count changed in a similar way as the mean corpuscu-
lar volume and the mean cell haemoglobin. The platelet
count decreased from a mean value of 280.55 ± 64.40 ×
103/μl in the first trimester to 234.15 ± 67.67 × 103/μl in
the third trimester (Table 2).
Comparisons across trimesters
The mean values for each variable (table 2) were com-
pared between trimesters. The differences in the mean
haemoglobin concentrations between the first and second
trimesters, between the first and third trimesters and
between the second and third trimesters were found to be
statistically significant (p < 0.01). Similarly, the differ-
ences between the means across the three trimesters were
statistically significant for the MCV (p < 0.01), WBC (p <
0.01) and the MCH (p < 0.01). A comparison of the
means between the first and second trimester for the PCV
was statistically significant (p = 0.001), but this was not so
when the first and third or the second and third trimesters
were compared. For the MCHC a statistically significant
difference was observed only between the first and second
trimester. In analyzing the red blood cell count, a statisti-
cally significant difference was observed between trimes-
ters 1 and 3 and trimesters 2 and 3 while for the platelets
the differences between the means observed across the
three trimesters were not statistically significant.
A comparison of the 5th percentile for the group with the
quoted standards for haemoglobin concentration showed
close correlation. For the 1st trimester the 5th percentile
was 11.59 g/dl whereas the international standard is 11.0
g/dl. For the 2nd trimester the 5th percentile is 10.25 vs.
10.5 g/dl and for the 3rd it is 10.5 vs. 11.0 g/dl.
Discussion
As indicated in the introduction, haematological abnor-
malities, especially anaemia, may have an adverse impact
on maternal and foetal well-being and pregnancy out-
come. Significant effort is therefore given to monitoring
and responding to haematological parameters. So far in
most populations as in Jamaica this is based on interna-
tional norms. From a search of the literature this appears
to be the first attempt to compare haematological indices
for anaemia in a Jamaican population with international
norms and to determine their suitability as a standard for
the population.
Haemoglobin concentrations generally remain stable
until about the 16th week of gestation after which there is
a steady fall until it reaches its lowest point in the second
trimester as a result of the expansion of the plasma vol-
ume. It is then expected that the haemoglobin concentra-
tion will remain constant or rise slightly during the third
Table 2: Mean (± S.D) haematological values over the three trimesters of pregnancy in primigravid women in the study population.
Parameters Trimester 1 Trimester 2 Trimester 3 p-value
1st & 2nd 1st & 3rd 2nd & 3rd
RBC (× 106/μl) 4.33 ± 0.40 3.80 ± 0.33 3.94 ± 0.36 0.000* 0.054 0.000*
Hb (g/dl) 12.73 ± 1.14 11.41 ± 1.16 11.67 ± 1.18 0.000* 0.000* 0.009*
PCV (%) 37.05 ± 2.96 33.12 ± 3.00 34.03 ± 2.97 0.000* 0.000* 0.000*
MCH (pg) 29.53 ± 2.92 30.15 ± 3.01 29.85 ± 3.13 0.001* 0.000* 0.024*
MCHC (g/dl) 34.35 ± 1.05 34.42 ± 1.30 34.33 ± 1.43 0.753 0.457 0.373
MCV (fl) 85.89 ± 7.28 87.49 ± 7.02 86.70 ± 6.85 0.000* 0.819 0.001*
WBC (× 103/μl) 8.27 ± 2.60 9.66 ± 2.84 8.79 ± 2.50 0.000* 0.187 0.000*
Platelets (× 103/μl) 280.55 ± 64.40 250.32 ± 67.95 234.15 ± 67.67 0.000* 0.000* 0.000*
* indicates the level of significance p < 0.05.
Table legend text:
RBC – Red blood cell, Hb – Haemoglobin, PCV – Packed cell volume, MCH – Mean corpuscular haemoglobin, MCHC – Mean corpuscular 
haemoglobin concentration, MCV – Mean corpuscular volume, WBC – White blood cellPublish with BioMed Central    and   every 
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trimester when sufficient iron is available [2,4,8,11-13].
The results of this study are in keeping with expected
trends and showed a decrease in haemoglobin concentra-
tion from the first to the second trimester followed by a
slight increase in the third trimester. The results also indi-
cate that the women maintained a good haemoglobin
concentration throughout pregnancy as the mean values
did not fall below the cut-off point for anaemia during
any of the three trimesters. If the case definition for anae-
mia of <5th percentile for the population was used the
results would correlate fairly well with the current stand-
ards used to define anaemia across the populations. The
changes in the red blood cell volume and packed cell vol-
umes were similar to that in haemoglobin concentration
in keeping with previous reports. The increase in these
three parameters is a reflection of adequate iron supply
resulting in increased haemoglobin production. However,
the role of nutrition and or iron supplementation was not
evaluated.
Conclusion
In conclusion, the results of this first comprehensive study
of the haematological profile of the Jamaican primigrav-
ida suggests that there is no significant difference in the
haematological profile of the primigravid Jamaican
woman when compared to international norms. This sug-
gests that the international standards for anaemia in preg-
nancy are applicable to the Jamaican primigravid woman.
This finding may be reassuring to others with a similar
population and stage of development as Jamaica and sug-
gest that they are applicable across populations.
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